Sprint Bioscience AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Björn Sjöstrand, was filed 11 Dec 2025.
Sprint Bioscience AB: what insiders have been doing
Every trade that managers of Sprint Bioscience AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. In the past year (29 October 2025 to 29 October 2026), 4 filings came from 2 insiders.
No insider sold shares on the market over the period. Instead, the filings list 4 purchases totalling €16k, made by 2 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €5,057, the purchase published on 30 November 2025 by Björn Sjöstrand is the largest of the period. Among those who bought: 1 board member and 1 chief executive.
Across the 1,033 companies tracked on its exchange, the median is 9 filings; at 4 filings, this issuer sits below that mark. Since 2016, the database holds 30 purchases and no sales by insiders of the company.
The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 11 December 2025, 332 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (MAR article 19).
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2021FY ended December 2021 · cache
- 30,000 shares@ SEK 1.450.013% mcap16.6% of flowAktieISIN SE0006343745FI:A003U606-1Canonical exit: 10 Mar 2026 (T+90)
- 23,750 shares@ SEK 1.640560.4% of flowAktieISIN SE0006343745FI:csv-d03a1fe513eb25c87ef0Canonical exit: 1 Mar 2026 (T+90)
- 35,108 shares@ SEK 1.583539.9% of flowAktieISIN SE0006343745FI:csv-f18725e545211db61f69Canonical exit: 26 Feb 2026 (T+90)
- 24,872 shares@ SEK 1.59928.5% of flowAktieISIN SE0006343745FI:csv-5d7f24e664689cb2d719Canonical exit: 26 Feb 2026 (T+90)
- 335,520 shares@ SEK 0.66BTA (betald tecknad aktie)ISIN SE0016609804FI:csv-34268ca98735d1481392
- 606,617 shares@ SEK 0.66BTA (betald tecknad aktie)ISIN SE0016609804FI:csv-be0bf8822463da7ff7ec
- 333,520 shares@ SEK 0.6683.4% of flowBTA (betald tecknad aktie)ISIN SE0016609804FI:A003N847-2
- 6,432,591 shares@ SEK 0.66BTA (betald tecknad aktie)ISIN SE0016609804FI:csv-f689d97c53957509c560Canonical exit: 23 Jul 2025 (T+90)
- 500,000 shares@ SEK 0.1269.2% of flowTeckningsoptionFI:csv-1af90533bd3c1275032b
- 20,000 shares@ SEK 1.29530.8% of flowAktieISIN SE0006343745FI:csv-25733fec39ba698988aaCanonical exit: 21 Mar 2024 (T+90)
- 20,000 shares@ SEK 2.10100.0% of flowAktieISIN SE0006343745FI:csv-93c6a22fb16aca368f45Canonical exit: 19 Feb 2024 (T+90)
- 20,000 shares@ SEK 2.1062.4% of flowAktieISIN SE0006343745FI:csv-ec3f04b577a69b74339cCanonical exit: 19 Feb 2024 (T+90)
- 32,000 shares@ SEK 1.0221.3% of flowAktieISIN SE0006343745FI:csv-097a35e59daf8d0c43e2Canonical exit: 23 Nov 2023 (T+90)
- 2,000 shares@ SEK 0.981.3% of flowAktieISIN SE0006343745FI:csv-332a1b4dec8a393c37e8Canonical exit: 23 Nov 2023 (T+90)
- 4,891,836 shares@ SEK 0.7514.5% of flowBTU (betald tecknad unit)ISIN SE0019018946FI:csv-3db7698bf6a5350f6b37
- 441,177 shares@ SEK 0.7523.1% of flowBTU (betald tecknad unit)ISIN SE0019018946FI:csv-e9fbfdb78b5832b5dc56
- 1,750 shares@ SEK 0.750.1% of flowBTU (betald tecknad unit)ISIN SE0019018946FI:csv-55132fb766a55de9a9fa
- 4,891,836 shares@ SEK 0.75100.0% of flowBTU (betald tecknad unit)ISIN SE0019018946FI:csv-9cc949cd3282a9dcc514
- 248,896 shares@ SEK 0.750.7% of flowBTA (betald tecknad aktie)ISIN SE0019018946FI:csv-1cbad3803307ba396cb1
- 100,000 shares@ SEK 0.75100.0% of flowBTU (betald tecknad unit)ISIN SE0019018946FI:csv-53e0058368e9c25b13e6Canonical exit: 13 Feb 2023 (T+90)
- 3,726 shares@ SEK 4.6630.1% of flowAktieISIN SE0006343745FI:csv-2e6cbd01e0489670e35fCanonical exit: 19 Dec 2021 (T+90)
- 4,486 shares@ SEK 4.820.1% of flowAktieISIN SE0006343745FI:csv-60e2f5c9c2ca0b36a4fdCanonical exit: 12 Dec 2021 (T+90)
- 33,831 shares@ SEK 4.930.7% of flowAktieISIN SE0006343745FI:csv-f740418ff67b0fd5d1fcCanonical exit: 9 Dec 2021 (T+90)
- 34,040 shares@ SEK 4.9640.7% of flowAktieISIN SE0006343745FI:csv-592263f1bf0bf84c9a53Canonical exit: 8 Dec 2021 (T+90)
- 374,532 shares@ SEK 5.348.4% of flowBTA (betald tecknad aktie)ISIN SE0016609804FI:csv-5307725c37bc34414f79
25 of 49 declarations
About Sprint Bioscience AB
Sprint Bioscience AB is a Swedish company focused on developing drugs for cancer treatment. It specializes in the discovery and development of new targeted therapies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
